Clinical Trial Update: Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-IV: (LONG-DES-IV) [Phase 4]

View source ↗

Summary

A Phase 4 study (LONG-DES-IV) evaluating percutaneous treatment of long native coronary lesions with a drug-eluting stent has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Drug-eluting stent (drug-eluting stent)

Snippet

Sponsor: Seung-Jung Park | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED